Colitis: all 1,059 studies

Page 3 of 11. Open to participants first (124), then studies with results posted, then the rest; newest registration first within each.

• A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's DiseaseCompletedNCT02620046Phase 3Results posted
• A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative ColitisCompletedNCT02618187Phase 1Results posted
• Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative ColitisCompletedNCT02611830Phase 3Results posted
• An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative ColitisCompletedNCT02601300Phase 2Results posted
• A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT02589665Phase 2Results posted
• Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's DiseaseCompletedNCT02559713Phase 4Results posted
• Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative ColitisCompletedNCT02536404Phase 2Results posted
• Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)CompletedNCT02522780Phase 3Results posted
• Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)CompletedNCT02522767Phase 3Results posted
• Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative ColitisTerminatedNCT02520284Phase 2/3Results posted
• A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical PracticeCompletedNCT02499263Results posted
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative ColitisCompletedNCT02497469Phase 3Results posted
• A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-MCompletedNCT02493712Phase 2Results posted
• Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative ColitisCompletedNCT02447302Phase 2Results posted
• Correlation of Infliximab Levels With Outcomes in Ulcerative ColitisCompletedNCT02438410Results posted
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative ColitisCompletedNCT02435992Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT02407236Phase 3Results posted
• Evaluation of 3D Visualization for Total ColectomyCompletedNCT02370056Not applicableResults posted
• Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in RemissionCompletedNCT02365480Phase 1Results posted
• Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's ColitisCompletedNCT02330653Phase 1/2Results posted
• To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)TerminatedNCT02326155Results posted
• Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).CompletedNCT02318667Phase 4Results posted
• Efficacy and Safety Study of Apremilast to Treat Active Ulcerative ColitisCompletedNCT02289417Phase 2Results posted
• Low Dose IL-2 for Ulcerative ColitisCompletedNCT02200445Phase 1Results posted
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT02171429Phase 3Results posted
• A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT02165215Phase 3Results posted
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT02163759Phase 3Results posted
• Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)CompletedNCT02155335Phase 4Results posted
• A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT02136069Phase 3Results posted
• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III StudiesTerminatedNCT02118584Phase 3Results posted
• Fecal Microbiota Transplantation in Pediatric PatientsCompletedNCT02108821Phase 1Results posted
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT02100696Phase 3Results posted
• Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative ColitisCompletedNCT02093663Phase 3Results posted
• Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuoTerminatedNCT02092389Results posted
• Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)CompletedNCT02092285Phase 4Results posted
• Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative ColitisCompletedNCT02065622Phase 3Results posted
• Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative ColitisCompletedNCT02065557Phase 3Results posted
• FMT in Ulcerative Colitis-Associated PouchitisCompletedNCT02049502Phase 2Results posted
• Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative ColitisCompletedNCT02039505Phase 3Results posted
• MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis PatientsCompletedNCT01959165Phase 2Results posted
• Efficacy and Safety of Fecal Microbiota Transplantation for Severe Clostridium Difficile Associated ColitisTerminatedNCT01959048Not applicableResults posted
• Trichuris Suis Ova Treatment in Left-sided Ulcerative ColitisTerminatedNCT01953354Phase 2Results posted
• Special Investigation in Patients With Ulcerative ColitisCompletedNCT01947816Results posted
• TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC)CompletedNCT01903252Phase 3Results posted
• A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.CompletedNCT01863771Phase 3Results posted
• Web-based Monitoring in Children and Adolescents With Inflammatory Bowel DiseaseCompletedNCT01860651Not applicableResults posted
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative ColitisCompletedNCT01831427Phase 1Results posted
• A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative ColitisTerminatedNCT01805791Phase 3Results posted
• A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)CompletedNCT01804166Phase 4Results posted
• Long-Term Safety Of PF-00547659 In Ulcerative ColitisCompletedNCT01771809Phase 2Results posted
• Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeCompletedNCT01768858Results posted
• Bacteriotherapy in Pediatric Inflammatory Bowel DiseaseCompletedNCT01757964Phase 1Results posted
• Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)TerminatedNCT01716039Phase 2Results posted
• A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative ColitisTerminatedNCT01706159Phase 2Results posted
• Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative ColitisCompletedNCT01694485Phase 2Results posted
• Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)CompletedNCT01692743Phase 3Results posted
• Efficacy of Gralise® for Chronic Pelvic PainTerminatedNCT01678911Phase 4Results posted
• Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative ColitisTerminatedNCT01671956Phase 2Results posted
• Efficacy and Safety Study of Ozanimod in Ulcerative ColitisCompletedNCT01647516Phase 2Results posted
• A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative ColitisCompletedNCT01620255Phase 2Results posted
• A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)CompletedNCT01562314Phase 2Results posted
• A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice SettingCompletedNCT01550965Phase 3Results posted
• Predicting Response to Standardized Pediatric Colitis TherapyCompletedNCT01536535Phase 4Results posted
• Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)CompletedNCT01532648Phase 3Results posted
• Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing ColonoscopyCompletedNCT01520324Phase 2Results posted
• Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative ColitisCompletedNCT01506362Phase 2Results posted
• The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis PatientsCompletedNCT01493960Phase 3Results posted
• Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative ColitisCompletedNCT01482884Phase 2Results posted
• Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.CompletedNCT01477320Not applicableResults posted
• Long-Term Study Of CP-690,550 In Subjects With Ulcerative ColitisCompletedNCT01470612Phase 3Results posted
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative ColitisCompletedNCT01465763Phase 3Results posted
• A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative ColitisCompletedNCT01458951Phase 3Results posted
• A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative ColitisCompletedNCT01458574Phase 3Results posted
• A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative ColitisCompletedNCT01456052Phase 2Results posted
• Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis OvaCompletedNCT01433471Not applicableResults posted
• Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative ColitisCompletedNCT01393405Phase 2Results posted
• Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFsCompletedNCT01387594Phase 1Results posted
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)CompletedNCT01369355Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)CompletedNCT01369342Phase 3Results posted
• Intracolonic Vancomycin Therapy in Severe C. Diff ColitisTerminatedNCT01346059Not applicableResults posted
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)CompletedNCT01340872Phase 3Results posted
• Oral OKT3 for the Treatment of Active Ulcerative ColitisCompletedNCT01287195Phase 1/2Results posted
• Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis PatientsCompletedNCT01284062Phase 2Results posted
• Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative ColitisCompletedNCT01171807Phase 2Results posted
• Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative ColitisCompletedNCT01130844Phase 1Results posted
• Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative ColitisCompletedNCT01124149Phase 4Results posted
• Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated DysplasiaTerminatedNCT01111292Phase 1/2Results posted
• (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release TabletsCompletedNCT01100112Phase 3Results posted
• Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease ActivityCompletedNCT01065571Not applicableResults posted
• Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative ColitisCompletedNCT01059344Phase 3Results posted
• Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated DiarrheaCompletedNCT01058356Results posted
• Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative ColitisCompletedNCT01036022Phase 2Results posted
• Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative ColitisTerminatedNCT01004185Phase 3Results posted
• An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal SurgeryTerminatedNCT01002287Not applicableResults posted
• Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)TerminatedNCT00984568Phase 3Results posted
• Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel DiseasesCompletedNCT00940576Not applicableResults posted
• A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT00853099Phase 3Results posted
• The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative ColitisTerminatedNCT00805285Phase 2Results posted
• (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.CompletedNCT00801723Phase 3Results posted
• Melatonin and Ulcerative Colitis: A Pilot Clinical TrialTerminatedNCT00790478Phase 2Results posted

← Colitis overview